Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Cellectis S.A. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −6 vs. Q4 2022
- Shares held
- 15.2M
- +6.47M (+74.1%) vs. Q4 2022
- Total value
- $29.3M
- +$11.0M (+59.7%) vs. Q4 2022
- New holders
- 6
- 11 more added
- Sold out
- 12
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Long Focus Capital Management, LLC | 4,487,293 | $8.66M | 1.40% | +1,803,660+67.2% | Added |
| Bpifrance SA | 2,186,960 | $4.22M | 0.11% | +2,186,960 | New |
| Capital International Investors | 1,848,804 | $3.57M | 0.00% | +1,400,000+311.9% | Added |
| Baillie Gifford & Co | 1,639,896 | $3.16M | 0.00% | +1,040,000+173.4% | Added |
| Credit Suisse AG | 1,438,255 | $2.78M | 0.00% | 00.0% | Unchanged |
| Principal Financial Group Inc | 1,361,860 | $2.63M | 0.00% | +27,810+2.1% | Added |
| Millennium Management LLC | 1,180,059 | $2.28M | 0.00% | +500,093+73.5% | Added |
| Macquarie Group Ltd | 226,875 | $438.0K | 0.00% | 00.0% | Unchanged |
| KBC Group NV | 163,447 | $315.0K | 0.00% | 00.0% | Unchanged |
| CVI Holdings, LLC | 129,434 | $249.8K | 0.09% | +129,434 | New |
| D. E. Shaw & Co., Inc. | 122,530 | $236.5K | 0.00% | −104,582−46.0% | Reduced |
| Oppenheimer & Co Inc | 116,163 | $224.2K | 0.00% | +41,111+54.8% | Added |
| Morgan Stanley | 77,702 | $150.0K | 0.00% | +3,561+4.8% | Added |
| Jane Street Group, LLC | 50,522 | $99.8K | 0.00% | −160,945−76.1% | Reduced |
| Vontobel Holding Ltd. | 30,000 | $57.9K | 0.00% | +16,000+114.3% | Added |
| Old Mission Capital LLC | 22,329 | $43.1K | 0.00% | +10,577+90.0% | Added |
| Envestnet Asset Management Inc | 42,868 | $37.0K | 0.00% | −14,579−25.4% | Reduced |
| Wells Fargo & Company | 16,479 | $31.8K | 0.00% | −500−2.9% | Reduced |
| LPL Financial LLC | 12,357 | $23.8K | 0.00% | +12,357 | New |
| One68 Global Capital, LLC | 11,000 | $21.2K | 0.03% | +11,000 | New |
| Geode Capital Management, LLC | 10,776 | $20.8K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 9,155 | $17.7K | 0.00% | +2,036+28.6% | Added |
| Advisor Group Holdings, Inc. | 6,210 | $12.0K | 0.00% | −27−0.4% | Reduced |
| National Bank of Canada | 3,600 | $6.95K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,755 | $5.32K | 0.00% | 00.0% | Unchanged |
| Assetmark, Inc | 1,911 | $3.69K | 0.00% | +391+25.7% | Added |
| JPMorgan Chase & Co | 1,341 | $3.00K | 0.00% | −257−16.1% | Reduced |
| TD Waterhouse Canada Inc. | 360 | $720 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 330 | $637 | 0.00% | −5,117−93.9% | Reduced |
| Barclays PLC | 28 | $54 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 13 | $25 | 0.00% | +13 | New |
| Royal Bank of Canada | 65 | $0 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 31 | $0 | 0.00% | +31 | New |
| Sofos Investments, Inc. | 2 | – | – | 00.0% | Unchanged |
| Capital World Investors | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −58,207−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −58,087−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −26,362−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −19,365−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −18,208−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −515−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −263−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −147−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |